ORIGINAL ARTICLE |
|
Year : 2022 | Volume
: 32
| Issue : 1 | Page : 23-28 |
|
Assessment of aortic stiffness by transthoracic echocardiographic in young COVID-19 patients
Asli Kurtar Mansiroglu, Tuba Disikirik, Hande Seymen, Mehmet Cosgun, Isa Sincer
Department of Cardiology, Abant Izzet Baysal University Hospital, Bolu, Turkey
Correspondence Address:
Asli Kurtar Mansiroglu Department of Cardiology, Abant Izzet Baysal University Hospital, Bolu 14280 Turkey
 Source of Support: None, Conflict of Interest: None  | Check |
DOI: 10.4103/jcecho.jcecho_65_21
|
|
Background: Deteriorated aortic elasticity is part of the atherosclerotic process. Inflammation is an underlying factor in both COVID-19 and atherosclerosis. Aims and Objectives: Using aortic elastic properties, we aimed to assess the subclinical indicators of susceptibility to inflammatory atherosclerosis in patients with COVID-19. Materials and Methods: Out of 194 participants included in this study, 100 were diagnosed with COVID-19 in the last 6 months (60 women and 40 men with a mean age of 34.13 ± 6.45 years) and 94 were healthy controls (55 women and 39 men with a mean age of 30.39 ± 7.21 years). We analyzed transthoracic echocardiographic and aortic stiffness parameters in all participants. Results: Values of systolic blood pressure (110 [85–140] vs. 110 [80–140], P = 0.037) and pulse pressure (PP) (37 [25–55] vs. 40 [25–55], P < 0.01) were significantly different between the groups. As for laboratory parameters, levels of glucose (97.89 ± 20.23 vs. 92.00 ± 9.95, P = 0.003) and creatinine (0.80 ± 0.13 vs. 0.75 ± 0.09, P = 0.003) were significantly higher in the COVID-19 group. Echocardiographic parameters showed that both groups differed significantly in diastolic aortic diameter (2.42 ± 0.28 vs. 2.31 ± 0.35, P = 0.017), aortic strain (9.66 [1.20–31.82] vs. 12.82 [2.41–40.11], P = 0.025), aortic distensibility (0.502 [0.049–2.545] vs. 0.780 [0.120–2.674], P < 0.01), and aortic stiffness (16.67 [4.19–139.43] vs. 11.71 [3.43–65.21], P = 0.006). Conclusion: Measurement of aortic stiffness is a simple, practical yet inexpensive method in COVID-19 patients, and therefore, may be used as an early marker for COVID-19-induced subclinical atherosclerosis.
|
|
|
|
[FULL TEXT] [PDF]* |
|
 |
|